Sven Thormahlen

Geen lopende functies

68 jaar

Consumer Non-Durables

Health Technology

Consumer Services

Profiel

Dr. Sven Thormahlen is Chief Technology Officer at Corbion NV.
He is on the Board of Directors at Accera, Inc. Dr. Thormahlen was previously employed as Executive Vice President-Research & Development by Danone SA, Chief Executive Officer by MucoVax GmbH, Outside Director by Yakult Honsha Co., Ltd., and Senior Vice President-Research & Development by L'Oréal SA. He received his graduate degree from the University of Hamburg and a doctorate degree from the University of Hamburg.

Eerdere bekende functies van Sven Thormahlen

Bedrijven	Functie	Einde
MucoVax GmbH	Algemeen Directeur	-
CORBION N.V.	Hoofd Techniek/Wetenschap/O&O	-
L'ORÉAL	Hoofd Techniek/Wetenschap/O&O	-
Cerecin, Inc. Cerecin, Inc. Pharmaceuticals: MajorHealth Technology Cerecin, Inc. develops therapies to treat central nervous system disorders. It offers therapeutic treatments for Parkinson's disease, Alzheimer's disease, and other age-related memory loss disorders. The firm is also developing therapies that address metabolic deficiencies and provide an alternative energy source for brain cells. The company was founded in 2001 and is headquartered in Boulder, CO.	Directeur/Bestuurslid	-
YAKULT HONSHA CO.,LTD.	Directeur/Bestuurslid	-

Ervaring van Sven Thormahlen in detail bekijken

Opleiding van Sven Thormahlen

University of Hamburg

Doctorate Degree

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit